1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Analysis of the US Cardiac Ablation Market

Analysis of the US Cardiac Ablation Market

  • May 2014
  • -
  • Frost & Sullivan
  • -
  • 125 pages

Methodology

• Primary interviews were conducted with key industry experts and regulatory authorities.
Designation of interviewed participants include chief executive officers, marketing managers,
directors, and vice presidents.
• Secondary research sources such as in-house Frost & Sullivan database, Frost & Sullivan’s
decision support database, company annual reports, scientific journals, and industry-related articles
have been utilized.
• The objective of the research service is to present a comprehensive analysis of the US cardiac
ablation market with respect to market potential and key market dynamics.
• The study also covers factors driving the growth, challenges affecting the industry, and
opportunities within the total market and the market segments as estimated for the forecast period.
• The study period covered by this service for the US cardiac ablation market is from 2010 to 2020,
with the base year as 2013 and forecast period from 2014 to 2020.

Key Findings
• The US cardiac ablation market is likely to grow at a robust CAGR through 2020, driven
primarily by growing incidence and prevalence of cardiac arrhythmias as well as increased
usage and adoption of premium-priced innovative ablation technologies.
• The market is forecast to reach $? billion by 2020. The key driving factors include a huge
unmet need from the pharmacological treatments, increasing number of ablation procedures
performed in the United States annually, and a surge in technology advancements of ablation
devices.
o In addition, complex ablation procedures and new modalities are other factors contributing
to the growth of ablation devices.
• More comprehensive clinical data will become available to support the safety and efficacy of
the catheter ablation techniques, which will significantly boost confidence among patients and
physicians, driving the adoption of these procedures.
• Furthermore, remote robotic navigation and ablation techniques are undergoing clinical
development that would provide additional benefits and boost the revenue growth in the atrial
fibrillation (AF) catheter ablation segment.
• The new mapping-catheters can now be integrated with the non-mapping catheters using a
3D modelling system. This trend is expected to gain significant momentum in the growing
ablation market.
o Many companies now realize the benefits of real-time navigation in 3D models, without
incurring additional costs.
ND56-54 16
• Research and development (R&D) activity has significantly increased in the catheter ablation
space with several companies investing in innovative technology; the electrophysiology (EP)
industry is likely to ensure the tremendous opportunity for a return on interest (ROI).
• The prevalence of AF increases with age. The patient pool for ablation procedures will also
continue to inflate in the United States because of a growing demographic population, with
more than ?% of AF cases occurring in patients between the ages of ?and?.
• Currently, only - major participants exist in the US cardiac ablation market space: Biosense
Webster (subsidy of Johnson & Johnson) and St. Jude Medical, constituting a combined
share of ?% in the US catheter ablation segment.
• Novel devices including CardioFocus' HeartLight Endoscopic Ablation System (EAS) laser
ablation catheter and force-sensing irrigated-tip RF ablation catheters such as Endosense's
TactiCath, Biosense Webster's ThermoCool SmartTouch, and Topera Medical’s RhythmView
3D Electrophysiologic Mapping System are expected to enter the market post 2014, spurring
market growth. These devices are expected to be offered at premium prices, and hence their
launch would have a direct impact on revenue.
• The strain created by the softening of the economy has led to a decrease in the purchase of
expensive capital equipment limiting the expansion of the EP lab systems market.
• With budgetary constraints and a mounting need for ablation procedures, the trend of
reprocessing diagnostic catheters is expected to increase, which will facilitate merger and
acquisition (M&A) activity by larger companies (e.g., Johnson & Johnson) to remain
competitive in the growing ablation market.

Table Of Contents

Analysis of the US Cardiac Ablation Market
1. EXECUTIVE SUMMARY
Executive Summary
Key Findings
Scope and Segmentation
Key Questions This Study Will Answer
Market Engineering Measurements
CEO's Perspective
Key Companies to Watch
Executive Summary—3 Big Predictions
2. MARKET OVERVIEW
Market Overview
Market Background
Market Overview—Definitions
Market Overview—Segmentation
Global Market Perspective
Defining Healthcare Trends in the Future
3. DISEASE OVERVIEW—EPIDEMIOLOGY
Disease Overview—Epidemiology
Lifetime Prevalence of Atrial Fibrillation
Patient Classification
Disease Overview
4. COST ANALYSIS AND DISEASE BURDEN
Cost Analysis and Disease Burden
Disease Overview—The Current Economic Burden
Costs of Atrial Fibrillation
Costs Analysis
5. COMPETITIVE PLAYBOOK
Competitive Playbook
New Market Opportunities
New Market Opportunities—Hybrid Procedure
Merger, Acquisition, and Partnership Assessment
6. DRIVERS, RESTRAINTS, AND TRENDS—TOTAL CARDIAC ABLATION MARKET
Drivers, Restraints, and Trends—Total Cardiac Ablation Market
Market Drivers
Drivers Explained
Market Restraints
Restraints Explained
Current Industry Challenges and Strategies
7. FORECASTS AND TRENDS—TOTAL CARDIAC ABLATION MARKET
Forecasts and Trends—Total Cardiac Ablation Market
Market Engineering Measurements
Forecast Assumptions and Definitions
Total Cardiac Ablation Market—Revenue Forecast
Total Cardiac Ablation Market—Revenue Forecast by Segments
Revenue Forecast Discussion
Pricing Analysis
Procurement Process
Reimbursement Trends
PESTLE Analysis
8. DEMAND ANALYSIS—TOTAL CARDIAC ABLATION MARKET
Demand Analysis—Total Cardiac Ablation Market
Penetration Analysis
Procedure Forecast
Disorder Prevalence and Treated Patient or Procedure Forecast Discussion
9. COMPETITIVE ENVIRONMENT
Competitive Environment
Market Share
Market Share Analysis
Top Competitors
Cardiac Ablation—Technology Roadmap
10. CATHETER ABLATION SEGMENT BREAKDOWN
Catheter Ablation Segment Breakdown
Catheter Ablation Segment Overview
Catheter Ablation Segment Key Findings
Market Engineering Metrics
Catheter Ablation Segment—Revenue Forecast
Revenue Forecast Discussion
11. SURGICAL ABLATION SEGMENT BREAKDOWN
Surgical Ablation Segment Breakdown
Surgical Ablation Segment Overview
Surgical Ablation Segment Key Findings
Market Engineering Metrics
Surgical Ablation Segment—Revenue Forecast
Revenue Forecast Discussion
12. CARDIAC MAPPING SEGMENT BREAKDOWN
Cardiac Mapping Segment Breakdown
Cardiac Mapping Segment Overview
Cardiac Mapping Segment Key Findings
Market Engineering Metrics
Cardiac Mapping Segment—Revenue Forecast
Revenue Forecast Discussion
Product Profiling
13. THE LAST WORD
The Last Word
The Last Word—3 Big Predictions
The Last Word—Discussion
Legal Disclaimer
14. APPENDIX
Appendix
Market Engineering Methodology
List of Selected Market Participants
Learn More—Next Steps

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way

Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the ...

Cardiovascular Surgical Devices: Technologies and Global Markets

Cardiovascular Surgical Devices: Technologies and Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Learn about the trends and developments affecting each type of cardiovascular surgical technology - Analyze trends and opportunities in major regions: North America, Europe, Asia ...

TCR/CAR-T Therapies in Oncology: Analytical Tool

TCR/CAR-T Therapies in Oncology: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.